Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis.
CONCLUSIONS: Baseline tumor marker panel including CYFRA 21-1, CEA and NSE can be prognostic of outcome for LA-SCCL receiving definitive radiotherapy. The RPA identified four prognostic subgroups, which could assist personalized therapy and clinical trial design in LA-SCCL.
PMID: 29958123 [PubMed - as supplied by publisher]
Source: Translational Oncology - Category: Cancer & Oncology Authors: Wang J, Jiang W, Zhang T, Liu L, Bi N, Wang X, Hui Z, Liang J, Lv J, Zhou Z, Xiao Z, Feng Q, Chen D, Yin W, Wang L Tags: Transl Oncol Source Type: research
More News: Borderline Tumor | Brain | Cancer & Oncology | Carcinoma | Clinical Trials | Neurology | Skin Cancer | Squamous Cell Carcinoma | Study